Aralen Phosphate Interactions
There are 503 drugs known to interact with Aralen Phosphate (chloroquine), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 197 are major, 293 are moderate, and 13 are minor.
- View all 503 medications that may interact with Aralen Phosphate
- View Aralen Phosphate alcohol/food interactions (1)
- View Aralen Phosphate disease interactions (10)
Most frequently checked interactions
View interaction reports for Aralen Phosphate (chloroquine) and the medicines listed below.
- amlodipine
- azathioprine
- beetroot
- belimumab
- Benlysta (belimumab)
- bisoprolol
- Breo Ellipta (fluticasone / vilanterol)
- Bricanyl (terbutaline)
- CellCept (mycophenolate mofetil)
- cephalexin
- Concerta (methylphenidate)
- Coumadin (warfarin)
- Dexilant (dexlansoprazole)
- Flexeril (cyclobenzaprine)
- folic acid
- furosemide
- hydrochlorothiazide
- Iron Sulfate (ferrous sulfate)
- levothyroxine
- methotrexate
- Nasonex (mometasone nasal)
- pantoprazole
- perindopril
- Plaquenil (hydroxychloroquine)
- prednisone
- progesterone
- Prometrium (progesterone)
- ranitidine
- scopolamine
- simvastatin
Aralen Phosphate alcohol/food interactions
There is 1 alcohol/food interaction with Aralen Phosphate (chloroquine).
Aralen Phosphate disease interactions
There are 10 disease interactions with Aralen Phosphate (chloroquine) which include:
- oculotoxicity
- porphyria
- arrhythmias
- bone marrow suppression
- ototoxicity
- seizures
- glucose-6-PD deficiency
- hepatotoxicity
- myasthenia gravis
- psoriasis
More about Aralen Phosphate (chloroquine)
- Aralen Phosphate consumer information
- Compare alternatives
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: amebicides
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.